Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASK0912 vs Polymyxin B in HABP/VABP
NCT07759934Phase 2Recruiting
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Mar 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ASK0912 in hospital-acquired bacterial pneumonia (HAP), ventilator-associated pneumonia (VAP), sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Mar 2026; status: recruiting.
02
Drugs
ASK0912
03
Conditions
hospital-acquired bacterial pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT07759934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759934.